A study of the antibiotic teicoplanin in adult patients with leukaemia, lymphoma or myeloma.
Phase 1
- Conditions
- Suspected or confirmed Gram-positive infection in patients with haematological malignancy.Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- EUCTR2013-004535-72-IE
- Lead Sponsor
- Tallaght Hospital, Dublin 24, Ireland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Haematological malignancy; 18 years or above; treated with teicoplanin for at least 3 days; suitable intravenous or intra-arterial access; written informed consent obtained.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 15
Exclusion Criteria
Consent not obtained; age <18 years; administered teicoplanin for <3 days; limited or no IV or intra-arterial access; receiving renal replacement therapy; admittance to the Intensive Care Unit.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method